News

Bret Gordon, DO, OB-GYN division chair at Saint Luke's Women's Health South, weighs in on what this means for women.

Melissa Magwire, RN, MSN, CDE, discusses the interrelated conditions of diabetes and cardiometabolic disease and how the Cardiometabolic Center of Excellence is changing the game for treatment.

Learn how the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence is making a difference in the lives of diabetes patients.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

KCTV talked to Melissa Magwire,RN, MSN, CDE, program director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence, to learn more about the Cardiometabolic Center.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.

Carmon is living with type 2 diabetes, but her life is much fuller now because of the care she received at Saint Luke’s Cardiometabolic Center of Excellence.